Safety considerations with the use of platelet inhibitors for elderly patients with non-ST- elevation acute coronary syndrome

M. E. Gimbel*, J. M. Ten Berg

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Number of pages8
JournalExpert opinion on drug safety
DOIs
Publication statusE-pub ahead of print - 13 Jun 2021

Keywords

  • Antiplatelet therapy
  • elderly
  • non-ST elevation acute coronary syndrome
  • percutaneous coronary intervention
  • cyp2c19
  • platelet function testing
  • de-escalation
  • DUAL ANTIPLATELET THERAPY
  • OPEN-LABEL
  • TICAGRELOR MONOTHERAPY
  • ANTITHROMBOTIC THERAPY
  • CARDIOVASCULAR EVENTS
  • MYOCARDIAL-INFARCTION
  • STENT IMPLANTATION
  • EUROPEAN-SOCIETY
  • BLEEDING EVENTS
  • POSITION PAPER

Cite this